Physician profile
Barbara Lee
NPI 1508836040
$2,014.72
in general payments reported to CMS, 2019-2025
16 companies · $243 in 2025
The $243 reported for 2025 was more than what 79% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $236 · 2021: $224 · 2022: $255 · 2023: $415 · 2024: $406 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $576.60 | 2019-2025 | Bexsero, Pediarix |
| Merck Sharp & Dohme LLC | $410.78 | 2019-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Pfizer INC. | $327.48 | 2019-2023 | |
| Sanofi Pasteur INC. | $149.48 | 2021-2024 | |
| Cranial Technologies, INC | $139.52 | 2019-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $137.73 | 2023-2025 | |
| Phadia US INC. | $42.46 | 2022-2024 | Immunocap |
| Seqirus USA INC | $37.51 | 2025 | Flucelvax |
| Alexion Pharmaceuticals, INC. | $29.00 | 2019 | |
| Exeltis, USA INC. | $27.46 | 2025 | Slynd |
| Mayne Pharma Commercial LLC | $25.45 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $24.44 | 2023 | Flumist Quadrivalent |
| Hologic Sales and Service, LLC | $24.23 | 2023 | Aptima |
| Alk-Abello, INC | $21.57 | 2025 | Neffy |
| Verrica Pharmaceuticals INC. | $21.47 | 2023 | Ycanth |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lnhc, INC | $19.54 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.